project-logo

Dermavir (GIC)

Pre-ICO starts
30.03.2018 00:00
Pre-ICO ends
15.05.2018 00:00
ICO starts
15.05.2018 00:00
ICO ends
30.05.2018 00:00
Token
GIC
Base
Ethereum
Category
Drugs & Healthcare
Country
Hungary
Leader

Features

Therapeutic Vaccine for treatment of HIV, referred to as “DermaVir”, is effective in boosting immune response which kills HIV-infected cells. Human clinical trials have demonstrated vaccine is capable of killing HIV-infected cells. DermaVir has a safety profile similar to vaccines used in healthy adults and children. DermaVir can also be a co-treatment option if administered with antiretroviral therapy.

ICO Details

Token Sales

Token price in USD: 1 Token = 1.000000 USD

Token distribution:
66% - ICO
3% - Bounty
21% - future sell

Funds allocation:
15% - FDA Documentation
19% - Vaccines Design Team
19% - Salaries
4% - Experts fees
4% - Consultation fees
6% - Company Operations
4% - Legal
12% - Research
2% - Equipment
3% - Travel
6% - Patenting
6% - Reserve

Token

Type: Utility-token
Token Standard: ERC-20
Additional Token Emission: No

Bonuses

Presale 1st stage - 30% discount
Presale 2nd stage - 20% discount
Presale 3rd stage - 10% discount

Bounty campaign

3%

Accepts

ETH

Team

Subscribe to ICO BASE news

Be the first who get site's updates and other new features